These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28784688)

  • 1. Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.
    Runte KE; Bell SP; Selby DE; Häußler TN; Ashikaga T; LeWinter MM; Palmer BM; Meyer M
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Rate-Induced Myocardial Ca
    Silverman DN; Rambod M; Lustgarten DL; Lobel R; LeWinter MM; Meyer M
    J Am Heart Assoc; 2020 Sep; 9(17):e017215. PubMed ID: 32856526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fraction.
    Biering-Sørensen T; Cikes M; Lassen MCH; Claggett B; Minamisawa M; Santos ABS; Pieske-Kraigher E; Shah AM; Zile MR; McMurray JJV; Solomon SD; Cheng S
    Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1110-1119. PubMed ID: 37039073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
    van Empel VP; Mariani J; Borlaug BA; Kaye DM
    J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of Na
    Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
    Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of global and regional myocardial strains in patients with heart failure with a preserved ejection fraction vs hypertension vs age-matched control.
    Kim HY; Park SJ; Lee SC; Chang SY; Kim EK; Chang SA; Choi JO; Park SW; Kim SM; Choe YH; Oh JK
    Cardiovasc Ultrasound; 2020 Nov; 18(1):44. PubMed ID: 33172479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin directly improves diastolic function in human heart failure.
    Pabel S; Wagner S; Bollenberg H; Bengel P; Kovács Á; Schach C; Tirilomis P; Mustroph J; Renner A; Gummert J; Fischer T; Van Linthout S; Tschöpe C; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Hamdani N; Sossalla S
    Eur J Heart Fail; 2018 Dec; 20(12):1690-1700. PubMed ID: 30328645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
    Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM
    Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction.
    Das S; Frisk C; Eriksson MJ; Walentinsson A; Corbascio M; Hage C; Kumar C; Asp M; Lundeberg J; Maret E; Persson H; Linde C; Persson B
    Sci Rep; 2019 Feb; 9(1):3179. PubMed ID: 30816197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study).
    Cioffi G; Senni M; Tarantini L; Faggiano P; Rossi A; Stefenelli C; Russo TE; Alessandro S; Furlanello F; de Simone G
    Am J Cardiol; 2012 Feb; 109(3):383-9. PubMed ID: 22112740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Left Ventricular Relaxation and Left Atrial Function in Patients With Heart Failure and Preserved Ejection Fraction Versus Patients With Systemic Hypertension and Healthy Subjects.
    Okura H; Kataoka T; Yoshida K
    Am J Cardiol; 2016 Oct; 118(7):1019-23. PubMed ID: 27515892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased functional importance of the Na,Ca-exchanger in contracting failing human myocardium but unchanged activity in isolated vesicles.
    Diedrichs H; Frank K; Schneider CA; Burst V; Hagemeister J; Zobel C; Müller-Ehmsen J
    Int Heart J; 2007 Nov; 48(6):755-66. PubMed ID: 18160767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
    Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
    J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.